Details

Karakterizacija in kakovost aluminijevih zlitin za tlačno litje : diplomsko delo
ID Reitmeier, Matjaž (Author), ID Mrvar, Primož (Mentor) More about this mentor... This link opens in a new window

.pdfPDF - Presentation file, Download (1,52 MB)
MD5: 9CF96B800394DED7426B558EF89EC742
PID: 20.500.12556/rul/a7502131-25aa-4ae6-bb58-b162c386a326

Language:Slovenian
Keywords:tlačno litje, aluminijeve zlitine, karakterizacija, kakovost
Work type:High school thesis
Typology:2.11 - Undergraduate Thesis
Organization:NTF - Faculty of Natural Sciences and Engineering
Place of publishing:Ljubljana
Publisher:[M. Reitmeier]
Year:2016
Number of pages:V, 34 f.
PID:20.500.12556/RUL-89035 This link opens in a new window
UDC:621.74
COBISS.SI-ID:1646943 This link opens in a new window
Publication date in RUL:10.02.2017
Views:3233
Downloads:413
Metadata:XML DC-XML DC-RDF
:
REITMEIER, Matjaž, 2016, Karakterizacija in kakovost aluminijevih zlitin za tlačno litje : diplomsko delo [online]. Bachelor’s thesis. Ljubljana : M. Reitmeier. [Accessed 30 March 2025]. Retrieved from: https://repozitorij.uni-lj.si/IzpisGradiva.php?lang=eng&id=89035
Copy citation
Share:Bookmark and Share

Similar documents

Similar works from RUL:
  1. Systematic review and meta-analysis of observational studies evaluating treatment outcomes in patients with metastatic non-small-cell lung cancer on first-line immune checkpoint inhibitors therapy
  2. Description of adverse event of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer treated at the University Clinic Golnik
  3. Effectivness and safety of immunotherapy in patients with advanced non-small cell lung cancer in second line treatment at the University Clinic Golnik
  4. Evaluation of possible pembrolizumab dosing regimen racionalisation in advanced non-small cell lung cancer
  5. ǂThe ǂpotential of immunotherapies in the treatment of lung cancer
Similar works from other Slovenian collections:
  1. ǂThe ǂrole of immune checkpoint inhibitors in the treatment of cancer of unknown origin
  2. Trans-esophageal endobronchial ultrasound-guided needle aspiration (EUS-B-NA)
  3. Febrile neutropenia and grade 3/4 neutropenia in daily practice of adjuvant chemotherapy for non-small-cell lung cancer
  4. Advances in the therapy with immune-check point inhibitors (ICI) in non-small cell lung cancer (NSCLC) in 2022
  5. Long-term survival of locally advanced stage III non-small cell lung cancer patients treated with chemoradiotherapy and perspectives for the treatment with immunotherapy

Back